Guangzheng Eye Hospital Group Co., Ltd. (002524.SZ)
CNY 4.2
(-0.94%)
CNY 4.2
(-0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 38.9 Million | 124.32 Million | 145.37 Million | 154.98 Million | 79.04 Million | 321.05 Million |
| Net Income | 9.74 Million | -77.8 Million | 36.44 Million | 32.09 Million | 157.11 Million | -50.33 Million |
| Depreciation & Amortization | 100.33 Million | 100.01 Million | 106.39 Million | 62.63 Million | 98.41 Million | 98.01 Million |
| Deferred income taxes | -11.18 Million | -2.2 Million | -1.19 Million | -10.89 Million | 18.22 Million | -29.12 Million |
| Stock-based compensation | 3.34 Million | 1.26 Million | 5.97 Million | 13.13 Million | 10.71 Million | - |
| Change in working capital | -129.71 Million | -108.93 Million | 27.87 Million | 32.79 Million | -157.25 Million | 131.31 Million |
| Other non-cash items | 53.28 Million | 210.73 Million | -30.11 Million | 25.21 Million | -48.15 Million | 142.05 Million |
| Investing Cash Flow | -14.34 Million | -100.61 Million | 1.24 Million | -369.61 Million | 250.53 Million | -139.8 Million |
| Investments in PPE | -23.42 Million | -40.71 Million | -52.46 Million | -62.08 Million | -43.65 Million | -44.82 Million |
| Acquisitions | -8.6 Million | 1.81 Million | 83.89 Million | 194.51 Million | 287.55 Million | -1.8 Million |
| Investment purchases | - | -116.36 Million | -262.14 Million | -543 Million | -140.2 Million | -169 Million |
| Sales/Maturities of investments | 7.18 Million | 54.65 Million | 228.41 Million | 33.87 Million | 117.33 Million | 11.75 Million |
| Other Investing Activities | 9.07 Million | 1.32 | 3.54 Million | 7.08 Million | 29.5 Million | 64.06 Million |
| Financing Cash Flow | -13.92 Million | -11.75 Million | -209.84 Million | 78.02 Million | -473.02 Million | 34.98 Million |
| Debt repayment | -117.86 Million | -12.13 Million | -467 Million | -130.67 Million | -496.03 Million | -1.03 Billion |
| Dividends payments | -14.5 Million | -11.89 Million | -16.52 Million | -46.59 Million | -30.97 Million | -45.05 Million |
| Common Stock Repurchased | -12.27 Million | -3.06 Million | -22.71 Million | -29.53 Million | - | - |
| Common Stock Issuance | - | - | 22.71 Million | 29.53 Million | - | - |
| Other Financing Activities | -117.28 Million | 15.33 Million | 273.67 Million | 255.28 Million | 53.97 Million | 1.11 Billion |
| Accounts receivables | -54.01 Million | 48.69 Million | -23.57 Million | 28.84 Million | 80.48 Million | 95.84 Million |
| Accounts payables | -92.21 Million | -146.72 Million | 35.77 Million | 18.78 Million | -251.42 Million | 64.64 Million |
| Inventory | 27.71 Million | -8.7 Million | 16.87 Million | -3.93 Million | -4.53 Million | -53.1 Thousand |
| Other working capital | 4.23 Million | -2.2 Million | -1.19 Million | -10.89 Million | 18.22 Million | 131.36 Million |
| Cash at beginning of period | 56.97 Million | 45.02 Million | 108.25 Million | 244.84 Million | 388.29 Million | 172.06 Million |
| Cash at end of period | 67.6 Million | 56.97 Million | 45.02 Million | 108.25 Million | 244.84 Million | 388.29 Million |
| Capital Expenditure | -23.42 Million | -40.71 Million | -52.46 Million | -62.08 Million | -43.65 Million | -44.82 Million |
| Effect of forex changes on cash | - | - | - | - | 0.56 | - |
| Net cash flow / Change in cash | 10.62 Million | 11.95 Million | -63.23 Million | -136.59 Million | -143.44 Million | 216.23 Million |
| Free Cash Flow | 15.48 Million | 83.61 Million | 92.9 Million | 92.89 Million | 35.38 Million | 276.22 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.08 Million | 20 Million | -18.72 Million | 9.74 Million | -1.18 Million | 5.26 Million |
| Depreciation & Amortization | - | 25.63 Million | 25.63 Million | 100.33 Million | 100.33 Million | -49.78 Million |
| Deferred income taxes | - | - | - | -11.18 Million | - | 16.78 Million |
| Stock-based compensation | - | 6.98 Million | - | 3.34 Million | 3.34 Million | -146.81 Thousand |
| Change in working capital | - | 2.63 Million | - | -129.71 Million | -22.07 Million | 33.14 Million |
| Other non-cash items | 26.36 Million | 57.15 Million | 12.59 Million | 53.28 Million | -68.72 Million | 26.58 Million |
| Investing Cash Flow | 3.5 Million | 4.95 Million | -2.24 Million | -14.34 Million | 5.27 Million | -5.54 Million |
| Investments in PPE | -2.34 Million | -2.6 Million | -2.72 Million | -23.42 Million | -5.79 Million | -9.2 Million |
| Acquisitions | 4.01 Million | 576 Thousand | 130.00 | -8.6 Million | -34.81 Million | 25.59 Million |
| Investment purchases | - | - | - | - | 10 Million | -25.59 Million |
| Sales/Maturities of investments | 1.82 Million | 6.97 Million | 474.64 Thousand | 7.18 Million | 581.05 Thousand | 2.86 Million |
| Other Investing Activities | 4.01 Million | 7.55 Million | 474.77 Thousand | 9.07 Million | 11.07 Million | 788.28 Thousand |
| Financing Cash Flow | -65.35 Million | 20.57 Million | -17.62 Million | -13.92 Million | -19.86 Million | -21.67 Million |
| Debt repayment | -31.8 Million | -43.16 Million | -9.54 Million | -117.86 Million | -22.56 Million | -22.6 Million |
| Dividends payments | -4.23 Million | -4.06 Million | -3.64 Million | -14.5 Million | -3.85 Million | -4.68 Million |
| Common Stock Repurchased | - | - | - | -12.27 Million | -12.27 Million | 2.53 Million |
| Common Stock Issuance | - | - | - | - | - | -2.53 Million |
| Other Financing Activities | -29.31 Million | -18.53 Million | -23.52 Million | -117.28 Million | -38.57 Million | 5.6 Million |
| Accounts receivables | - | 1.51 Million | - | -54.01 Million | -54.01 Million | 47.55 Million |
| Accounts payables | - | - | - | -92.21 Million | - | 285.41 Thousand |
| Inventory | - | -5.77 Million | - | 27.71 Million | 27.71 Million | -14.4 Million |
| Other working capital | - | 6.89 Million | - | 4.23 Million | 4.23 Million | -285.41 Thousand |
| Cash at beginning of period | 112.31 Million | 41.59 Million | 67.6 Million | 56.97 Million | 73.84 Million | 72.08 Million |
| Cash at end of period | 52.99 Million | 112.31 Million | 41.59 Million | 67.6 Million | 67.6 Million | 73.84 Million |
| Capital Expenditure | -2.34 Million | -2.6 Million | -2.72 Million | -23.42 Million | -5.79 Million | -9.2 Million |
| Effect of forex changes on cash | - | - | - | - | - | -2.86 Million |
| Net cash flow / Change in cash | -59.31 Million | 70.71 Million | -26 Million | 10.62 Million | -6.23 Million | 1.75 Million |
| Free Cash Flow | 1.93 Million | 48.92 Million | -8.85 Million | 15.48 Million | 2.56 Million | 22.64 Million |
AAD
300575
002159
MDNA
300722
AZGFF